Skip to main content
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
5.84
+0.32 (5.80%)
At close: Nov 13, 2026, 4:00 PM EST
5.84
0.00 (0.00%)
After-hours: Nov 13, 2026, 4:15 PM EST

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7646468361,2361,3772,182
Market Cap Growth
24.70%-22.76%-32.38%-10.21%-36.91%-
Enterprise Value
5334095739631,0511,806
Last Close Price
5.525.056.499.1210.2116.32

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----534.4941969.36
Forward PE
-89.5626.14245.0644.39152.95
PS Ratio
3.673.214.176.418.3917.06
PB Ratio
2.251.892.113.153.245.38
P/TBV Ratio
2.622.102.333.493.355.59
P/FCF Ratio
--38.251952.94-8204.54
P/OCF Ratio
--32.94234.09-471.36
PEG Ratio
-1.341.341.34--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.552.032.864.996.4114.12
EV/EBITDA Ratio
----1527.81173.67
EV/EBIT Ratio
-----197.22
EV/FCF Ratio
--26.211522.10-6789.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.070.040.040.04-
Debt / EBITDA Ratio
----4.23-
Debt / FCF Ratio
--0.7822.33--
Net Debt / Equity Ratio
-0.72-0.70-0.66-0.63-0.76-0.90
Net Debt / EBITDA Ratio
5.967.2519.6011.39-469.56-35.06
Net Debt / FCF Ratio
17.1527.11-11.94-392.2214.70-1370.74
Asset Turnover
0.440.420.400.380.330.38
Inventory Turnover
1.842.091.701.521.551.76
Quick Ratio
3.734.295.005.677.9911.88
Current Ratio
4.465.045.866.979.2613.01
Return on Equity (ROE)
-23.20%-18.05%-1.53%-2.97%0.60%1.04%
Return on Assets (ROA)
-6.20%-5.25%-2.58%-3.43%-0.23%1.68%
Return on Invested Capital (ROIC)
-52.88%-33.82%-14.68%-22.52%-2.52%16.50%
Return on Capital Employed (ROCE)
-12.90%-10.50%-4.80%-6.40%-0.40%2.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.76%-10.30%-0.72%-0.98%0.19%0.14%
FCF Yield
-1.77%-1.36%2.61%0.05%-1.60%0.01%
Buyback Yield / Dilution
-0.94%2.19%3.45%2.37%-69.93%-150.13%
SEC Filings: 10-K · 10-Q